InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Monday, 05/11/2015 9:19:16 PM

Monday, May 11, 2015 9:19:16 PM

Post# of 80868
I like what I'm seeing. This is definitely an improvement from Q4.
I think it is positive that Musclepharm is defending it's sales in America....and that the decline in sales from last year's very strong Q1 sales can be explained almost entirely by a decline in international sales.

It makes perfect sense to me that Musclepharm focuses on America and a few International markets with strong currencies like UK and Australia right now.

Many purchasers from Brazil and elsewhere, probably delayed purchases for later, given the multi year lows of the Euro, the Brazilian real and the Canadian Dollar during Q1....so, more sales from there should be expected in Q2 after the 5-10% strengthening of these currencies versus the US dollar.

With Musclepharm's future endorsement and sponsorship contracts, it's natural to focus primarily on America though.

Musclepharm's goal should be to break even on US sales alone, and let international sales be the cream on the top...with $10-15 million contribution each quarter.